At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
mPAD (or TPAD) Pelvic Assist Device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Precision Gait Retraining for Children With Cerebral Palsy
In Brief
A clinical study evaluating mPAD (or TPAD) Pelvic Assist Device and No Intervention for Cerebral Palsy and Gait Disorders, Neurologic. Completed, enrolled 10 participants across 2 sites.
Detailed Summary
This project will develop the first sensor-based mobile Pelvic Assist Device (mPAD) that can deliver precise, adaptable, pelvic control to restore natural coordination of upper- and lower-limb movements during gait in children with Cerebral Palsy
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy, Gait Disorders, Neurologic
CountriesUnited States
CollaboratorsColumbia University
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartNov 2020
First PostedJan 2021
Primary CompletionJan 2021
TodayJul 2026
First PostedJan 22, 2021
Enrollment StartNov 11, 2020
Primary CompletionJan 31, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.4 years ago
Interventions
mPAD (or TPAD) Pelvic Assist Devicedevice
Gait retraining device that applies pelvic forces and measures response
No Interventiondevice
Gait with no pelvic assistance